Mesa Laboratories Inc (OQ:MLAB)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 08, 2024 08:00 am ET
MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the closing of its Amended and Restated Credit Agreement (the “Credit Agreement”), which provides up to $200 million of senior secured debt through a...
Apr 04, 2024 06:24 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 14, 2024, to...
Apr 01, 2024 10:27 am ET
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024. About Mesa Laboratories,...
Mar 15, 2024 07:00 am ET
Mesa Labs Releases Second Annual Responsible Business Program Brochure
Mesa Laboratories, Inc. (NASDAQ:MLAB, “Mesa” “we” “our” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced the release of its second annual Environmental,...
Feb 05, 2024 08:00 am ET
Mesa Labs Announces Third Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q24”) ended December 31, 2023. Third quarter...
Jan 08, 2024 08:00 am ET
Mesa Laboratories Appoints Mark Capone to its Board of Directors
Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us”, or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of...
Jan 04, 2024 03:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that on January 2, 2024 its Board of Directors declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on...
Jan 03, 2024 08:00 am ET
Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, announced the completed acquisition of GKE-GmbH’s sterilization...
Dec 14, 2023 10:47 am ET
Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, February 5, 2024. About Mesa Laboratories, Inc. Mesa is a global...
Nov 06, 2023 08:00 am ET
Mesa Labs Announces Second Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q24”) ended September 30, 2023. Second...
Oct 16, 2023 03:00 am ET
Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform
Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the completed acquisition of GKE-GmbH’s...
Oct 03, 2023 08:00 am ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15,...
Sep 13, 2023 01:37 pm ET
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, November 6, 2023. About Mesa Laboratories, Inc. Mesa is a global...
Aug 24, 2023 04:02 pm ET
Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions
Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced its commitment to calculate and disclose scope 1 and 2...
Aug 03, 2023 08:00 am ET
Mesa Labs Announces First Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q24”) ended June 30, 2023. First quarter...
Jul 05, 2023 03:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15,...
Jun 21, 2023 11:50 am ET
Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Thursday, August 3, 2023. About Mesa Laboratories, Inc. Mesa is a...
May 25, 2023 08:00 am ET
Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results
Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q23”) and fiscal year (“FY23”) ended March...
Apr 03, 2023 06:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2023, to...
Mar 13, 2023 08:00 am ET
Mesa Laboratories, Inc. Reports Immaterial Financial Exposure to Silicon Valley Bank Closure
Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or the “Company”) is a global leader in the design and manufacture of life science tools and critical quality control solutions. Mesa has monitored the situation at Silicon Valley Bank (“SVB”), whereby...
Mar 09, 2023 08:00 am ET
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2023 at approximately 8:00 A.M. Eastern time on Thursday, May 25, 2023. About Mesa Laboratories,...
Feb 13, 2023 07:00 am ET
Mesa Labs Releases Environmental, Social, and Governance Program Brochure
LAKEWOOD, Colo., Feb. 13, 2023 /PRNewswire/ -- Mesa Laboratories, Inc. (NASDAQ: MLAB, "Mesa" "we" "our" or the "Company"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today released its Environmental, Social, and Governance ("ESG")  Program Brochure. Central to Mesa's purpose of Protecting the Vulnerable®, the brochure describes Mesa's ongoing efforts regarding environmental, social, and corporate governance priorities, which are highly relevant to Mesa's business and its stakeholders.
Feb 06, 2023 08:36 am ET
Mesa Labs Announces Third Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q23”) ended December 31, 2022. Third...
Jan 03, 2023 05:00 pm ET
Mesa Labs Declares Quarterly Dividend
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 15, 2023,...
Dec 16, 2022 11:59 am ET
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2023 at approximately 8:00 A.M. Eastern time on Monday, February 6, 2023. About Mesa Laboratories, Inc. Mesa is a...
Nov 17, 2022 08:04 am ET
Mesa Labs Acquires Belyntic’s Peptide Purification Business
Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, today announced the...
Nov 04, 2022 03:49 pm ET
Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director
Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or the “Company”) today announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors (“Board”), effective November 3, 2022. Mr. Ladiwala assumes...
Nov 03, 2022 08:00 am ET
Mesa Labs Announces Second Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its second fiscal quarter (“2Q23”) and six months ended September 30, 2022. Financial highlights for the quarter and six months ended September 30, 2022 as compared to last year:...
Oct 03, 2022 02:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
October 3, 2022 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable...
Aug 04, 2022 08:00 am ET
Mesa Labs Announces First Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for its first fiscal quarter (“1Q23”). Financial Results (amounts in thousands, except per share data) In comparison to the same quarter in the prior year (“1Q22”), revenues increased...
Jul 06, 2022 07:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15,...
Jun 27, 2022 08:01 am ET
Mesa Laboratories Appoints Tony Tripeny to its Board of Directors
Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the “Board”), effective June 23, 2022. Tony was previously the Executive Vice President and Chief Financial Officer of Corning, Incorporated...
May 31, 2022 08:00 am ET
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q22”) and full year ended March 31, 2022 (“FY22”). Financial highlights for the quarter and year ended March 31, 2022, as compared to the same periods last...
Apr 06, 2022 01:10 pm ET
Mesa Labs Declares Quarterly Dividend
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2022,...
Feb 03, 2022 08:00 am ET
Mesa Labs Announces Third Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for its third fiscal quarter (“3Q22”) and nine months ended December 31, 2021. Financial highlights for the quarter and nine months ended December 31, 2021 as compared to the same...
Jan 06, 2022 03:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 15, 2022,...
Nov 04, 2021 08:00 am ET
Mesa Labs Announces Second Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its second fiscal quarter (“2Q22”) and six months ended September 30, 2021. Financial highlights for the quarter and six months ended September 30, 2021 as compared to last year:...
Oct 29, 2021 08:00 am ET
Leader in Corporate Development and Strategy Joins Mesa Labs Board of Directors
Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Shiraz Ladiwala to its Board of Directors, effective October 28, 2021. Shiraz previously worked in leadership roles at Thermo Fisher Scientific and retired on August 31, 2021....
Oct 20, 2021 12:05 pm ET
Mesa Labs Closes Acquisition of Agena Bioscience
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that it has completed the previously announced acquisition of Agena Biosciences, Inc. With this highly strategic acquisition, Agena’s innovative approach to molecular diagnostics is now paired...
Oct 01, 2021 03:00 pm ET
Mesa Labs Declares Quarterly Dividend
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15,...
Sep 14, 2021 07:00 am ET
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.
Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced...
Aug 05, 2021 08:00 am ET
Mesa Labs Announces First Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its first fiscal quarter (“1Q22”). Financial highlights for the quarter ended June 30, 2021 as compared to last year: Revenues increased 17%Operating income decreased 13%Non-GAAP...
Jul 06, 2021 07:19 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September...
Jun 01, 2021 08:00 am ET
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q21”) and full year ended March 31, 2021 (“FY21”). Financial highlights for the quarter and year ended March 31, 2021 as compared to last year:...
Apr 05, 2021 05:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on June 15,...
Feb 03, 2021 08:00 am ET
Mesa Labs Reports Third Quarter Results for FY21
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”) and nine months ended December 31, 2020. Financial highlights for the quarter and nine months ended December 31, 2020 as compared to last year:...
Jan 05, 2021 05:00 pm ET
Mesa Labs Declares Quarterly Dividend
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on March 15,...
Nov 05, 2020 08:00 am ET
Mesa Labs Reports Second Quarter Results for FY21
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020. Financial highlights for the quarter and six months ended September 30, 2020 as compared to last year:...
Oct 01, 2020 04:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on December...
Aug 06, 2020 08:00 am ET
Mesa Labs Reports First Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”). Financial highlights for the quarter ended June 30, 2020 as compared to last year: Revenues increased 14%Operating income decreased 41%Non-GAAP...
Jul 06, 2020 12:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on...
Jun 16, 2020 11:53 am ET
Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering
Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that the underwriters for its previously announced public offering of common stock have fully exercised their option to purchase 90,000 additional shares of Mesa Labs common...
Jun 09, 2020 08:15 pm ET
Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced the pricing of an underwritten public offering of 600,000 shares of its common stock at a public offering price of $225.00 per share for gross proceeds of approximately...
Jun 08, 2020 04:01 pm ET
Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock
Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock. In addition, Mesa Labs expects to grant the underwriters a 30-day option to...
Jun 01, 2020 08:00 am ET
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q20”) and full year ended March 31, 2020 (“FY20”). Financial highlights for the quarter and year ended March 31, 2020 as compared to last year: Revenues...
May 15, 2020 08:00 am ET
Life Sciences Executive Shannon Hall Joins Mesa Labs Board of Directors
Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced the election of Shannon Hall to its Board of Directors.  Shannon previously led the Life Sciences business at Bio-Rad Laboratories. Ms. Hall’s election fills the open position created by the...
Apr 01, 2020 06:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on June 15, 2020,...
Mar 16, 2020 11:04 am ET
Gyrolab Technology to be Incorporated Into Jefferson Institute for Bioprocessing Specialized Teaching Curriculum and Training Programs
Gyros Protein Technologies AB, a Mesa Laboratories, Inc. (NASDAQ:MLAB) company, and pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and the Jefferson Institute for Bioprocessing (JIB) at Thomas Jefferson University, a leading center of excellence providing advanced training to the bioprocessing industry, today announced that Gyrolab xPlore™ immunoassay system from Gyros Protein Technologies will be integrated into JIB’s curriculum. JIB’s industry training programs will also benefit from the technology to accelerate the generation of
Feb 10, 2020 08:00 am ET
Mesa Labs Reports Third Quarter Results
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, or “Mesa Labs”) today reported third quarter results for the three months ended December 31, 2019. Financial Results (amounts in thousands, except per share data) In comparison to the same...
Jan 09, 2020 07:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on March 16, 2020,...
Nov 06, 2019 08:00 am ET
Mesa Labs Reports Record Second Quarter Revenues and Adjusted Operating Income
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record second quarter revenues and adjusted operating income1 (“AOI”) for the three months ended September 30, 2019. Financial HighlightsIn comparison...
Oct 31, 2019 08:55 pm ET
Mesa Labs Acquires Gyros Protein Technologies
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding...
Oct 01, 2019 05:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on December 16,...
Aug 12, 2019 04:05 pm ET
Mesa Laboratories, Inc. Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options
Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced the closing of its previously announced concurrent underwritten public offerings of an aggregate of 431,250 shares of its common stock (the “Shares”) at a public offering price of...
Aug 07, 2019 11:20 pm ET
Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced the pricing of concurrent underwritten public offerings of (a) 375,000 shares of its common stock at a public offering price of $210.00 per share for gross proceeds, before deducting...
Aug 06, 2019 04:21 pm ET
Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock and Convertible Senior Notes
Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced that it has commenced concurrent underwritten public offerings of 375,000 shares of its common stock and $150 million aggregate principal amount of its convertible senior notes due...
Jul 30, 2019 08:00 am ET
Mesa Labs Reports Record First Quarter Revenues and Adjusted Operating Income
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record first quarter revenues and adjusted operating income1 (“AOI”) for the three months ended June 30, 2019. Financial HighlightsIn comparison to the...
Jul 09, 2019 03:00 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on September 16,...
Jun 03, 2019 10:00 am ET
Mesa Labs Reports Record Revenues and Adjusted Operating Income for Fiscal Year 2019
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted operating income1 for Fiscal Year 2019 (FY19). Record revenues for FY19 of $103.1M, 7% growth over FY18; fourth quarter...
Apr 17, 2019 08:30 am ET
Recent Analysis Shows TransEnterix, XOMA, Pixelworks, eGain, Mesa Laboratories, and Lantronix Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of TransEnterix, Inc. (NYSE:TRXC), XOMA Corporation (NASDAQ:XOMA), Pixelworks,...
Apr 08, 2019 01:44 pm ET
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on June 14, 2019,...
Mar 06, 2019 08:00 am ET
Mesa Labs Announces Changes in The Composition of Its Board of Directors
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) has announced several changes to the composition of its Board of Directors (the “Board”). As previously announced, on January 23, 2019 David B. Perez was appointed to...
Feb 04, 2019 08:00 am ET
Mesa Labs Reports Record Third Quarter Revenues and Adjusted Operating Income
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted operating income for the third quarter ended December 31, 2018. In comparison to the same quarter in the prior year, third...
Jan 08, 2019 08:00 pm ET
Mesa's Board Announces Death of Board Member H. Stuart Campbell
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that H. Stuart Campbell, Mesa’s Lead Independent Director has died at the age of 89.  “It is with great sadness and regret that we report the passing of H....
Jan 02, 2019 07:00 pm ET
Mesa Labs Declares Quarterly Dividend
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on March 15, 2019,...
Dec 03, 2018 04:00 am ET
Point Six Wireless Acquired by Mesa Labs
LEXINGTON, Ky., Dec. 3, 2018 /PRNewswire/ -- Point Six Wireless, LLC ("Point Six"), a leading continuous monitoring hardware business, today announced the acquisition of substantially all of the assets (other than current assets) and certain liabilities of its continuous monitoring business by Mesa Laboratories, Inc. (NASDAQ: MLAB) ("Mesa").
Nov 29, 2018 08:00 am ET
Mesa Labs Acquires Leading Continuous Monitoring Hardware Business
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of substantially all of the assets (other than current assets) and certain liabilities of the continuous monitoring business of Point Six...
Oct 31, 2018 08:00 am ET
Mesa Labs Reports Record Second Quarter Revenues
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues for the second quarter ended September 30, 2018. Revenues for the second quarter increased eight percent to $24,865,000 as compared to...
Oct 22, 2018 09:25 am ET
Analysis: Positioning to Benefit within Mesa Laboratories, World Acceptance, Mammoth Energy Services, Yintech Investment, Stamps, and Vera Bradley — Research Highlights Growth, Revenue, and Consolidat
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Mesa Laboratories, Inc. (NASDAQ:MLAB), World Acceptance Corporation...
Oct 02, 2018 01:00 pm ET
Mesa Labs Declares Quarterly Dividend
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on December 17,...
Jul 31, 2018 07:00 am ET
Mesa Labs Reports Record First Quarter Revenues and Net Income
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record first quarter revenues and net income for the three months ended June 30, 2018. Highlights for the quarter ended June 30, 2018 as compared to last...
Jul 09, 2018 06:00 pm ET
Mesa Labs Declares Quarterly Dividend
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on September 17,...
Jul 02, 2018 07:50 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within Antero Midstream, Generac Holdings, Town Sports International, Mesa Laboratories, Ultrapar Participacoes, and United Microelectronic
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Antero Midstream GP LP (NYSE:AMGP), Generac Holdings Inc. (NYSE:GNRC),...
Jun 05, 2018 07:00 am ET
Mesa Labs Reports Record Revenues and Adjusted Operating Income for the Fourth Quarter and Fiscal Year 2018
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenue and adjusted operating income for both the fourth quarter and Fiscal Year 2018. Highlights for the quarter ended March 31, 2018 as...
Apr 11, 2018 08:00 am ET
Mesa Labs Reports Transition of its Chief Sales and Marketing Officer
Gregory DiNoia Senior Vice President, Commercial Operations Succeeds Glenn Adriance, Retired Chief Sales and Marketing Officer
Apr 04, 2018 07:00 pm ET
Mesa Labs Declares Quarterly Dividend
           Lakewood, Colo., April 04, 2018 (GLOBE NEWSWIRE) -- – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend...
Feb 05, 2018 05:00 pm ET
Mesa Labs Reports Third Quarter Results
LAKEWOOD, Colo., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported its results for the third quarter ended December 31, 2017.
Feb 01, 2018 07:30 am ET
Report: Exploring Fundamental Drivers Behind Curis, Mesa Laboratories, Marin Software, Applied Materials, Plug Power, and Amazon — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Curis, Inc. (NASDAQ:CRIS), Mesa Laboratories, Inc....
Jan 02, 2018 03:34 pm ET
Mesa Labs Declares Quarterly Dividend
Lakewood, CO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common...
Nov 08, 2017 08:00 am ET
Mesa Labs Acquires Sterilization and Disinfection Process Control Business
LAKEWOOD, Colo., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of substantially all of the assets and certain liabilities of BAG Health Care GmbH’s (“BAG”)...
Nov 06, 2017 08:00 am ET
Mesa Labs Reports Second Quarter Results
LAKEWOOD, Colo., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported its results for the second quarter ended September 30, 2017.
Jun 07, 2017 07:00 am ET
Mesa Labs Reports Record Net Income and Adjusted Net Income
LAKEWOOD, Colo., June 07, 2017 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record net income and adjusted net income for the year ended March 31, 2017....
Feb 02, 2017 08:00 am ET
Mesa Labs Reports Record Third Quarter Revenues and Adjusted Net Income
LAKEWOOD, Colo., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted net income for the third quarter ended December 31, 2016....
Nov 02, 2016 08:00 am ET
Mesa Labs Reports Record Second Quarter Revenues and Adjusted Net Income
LAKEWOOD, Colo., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted net income for the second quarter ended September 30, 2016....
Oct 04, 2016 02:00 pm ET
Mesa Labs Declares Quarterly Dividend
LAKEWOOD, Colo., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on December 15, 2016, to shareholders of record at the close of business on November 30, 2016....
Aug 10, 2016 03:00 pm ET
Mesa Labs Acquires Cold Chain Manufacturing Capabilities
LAKEWOOD, Colo., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of certain assets and liabilities of Rapid Aid Corp (“Rapid Aid”) by the Company’s subsidiary, Mesa Canada, Inc. (“Mesa Canada”).  Rapid Aid was the Company’s exclusive supplier of cold chain packaging gel products (“CC Gels”).  The acquisition is expected to add approximately 550 basis points to Mesa’s Cold Chain Packaging Division gross profit margin and to be neutral to our diluted net income per share (“EPS”) during the first ...
Jul 28, 2016 08:00 am ET
Mesa Labs Reports 16 Percent Increase in First Quarter Revenues
LAKEWOOD, Colo., July 28, 2016 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported a 16 percent increase in revenues for the first quarter ended June 30, 2016....
Jul 06, 2016 11:53 am ET
Mesa Labs Declares Quarterly Dividend
LAKEWOOD, Colo., July 06, 2016 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on September 15, 2016, to shareholders of record at the close of business on August 31, 2016....
Jul 05, 2016 12:06 pm ET
Mesa Labs Acquires Additional Canadian Dental Sterilizer Testing Business
LAKEWOOD, Colo., July 05, 2016 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of certain assets and liabilities of HANSAmed Limited (“HANSAmed”) by the Company’s subsidiary, Mesa Canada, Inc. (“Mesa Canada”).  HANSAmed was a distributor of the Company’s biological indicator (“BI”) products and mail-in testing services to the dental market in Canada.  The acquisition is expected to add approximately $200,000 to Mesa’s revenues and to be accretive to our diluted net income per share during the first 12 months....
Jun 02, 2016 08:00 am ET
Mesa Labs Reports Record Net Income and Revenues
LAKEWOOD, Colo., June 02, 2016 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record net income and revenues for both the quarter and the year ended March 31, 2016....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.